SightfileU.S. market data from official filings

ADAPTIVE BIOTECHNOLOGIES COR (ADPT)

Name: ADAPTIVE BIOTECHNOLOGIES COR (ADPT) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001478320 · EDGAR filings · Updated 2026-07-23

ADAPTIVE BIOTECHNOLOGIES COR (ADPT) has 296 institutional managers reporting positions valued at $2.11B per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01).

Institutional managers

296

Reported 13F value

$2.11B

Insider activity

146 trans.

−$61.2M net selling

Data flags

1 active

from SEC filings

Filings this week (1)

2026-07-23 — Insider transaction reported (Form 4)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

2026-07-21 — Notice of proposed sale filed (Form 144)
2026-07-20 — Insider transaction reported (Form 4)
2026-07-17 — Insider transaction reported (Form 4)
2026-07-16 — Notice of proposed sale filed (Form 144)
2026-07-07 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ADAPTIVE BIOTECHNOLOGIES COR has 296 institutional holders.

Insider activity

Insiders reported 146 transactions (0 buys, 71 sells) across 11 reporting insiders, with a net reported value of −$61.2M.

Data flags from SEC filings

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2023-07-03 (recurring since 2023-07-03) — source filing. The authoritative details are those stated in the filing itself.

Related companies

KINIKSA PHARMACEUTICALS INTL (KNSA) · NEOGEN CORPORATION (NEOG) · AGIOS PHARMACEUTICALS INC (AGIO) · ULTRAGENYX PHARMACEUTICAL IN (RARE) · GENEDX HOLDINGS CORP COM CL A (WGS) · AMNEAL PHARMACEUTICALS INC (AMRX)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-23.